Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture - EP3122869

The patent EP3122869 was granted to Biogen MA on Aug 10, 2022. The application was originally filed on Mar 24, 2015 under application number EP15716252A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3122869

BIOGEN MA
Application Number
EP15716252A
Filing Date
Mar 24, 2015
Status
Patent Maintained As Amended
Jul 8, 2022
Publication Date
Aug 10, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANMar 5, 2020D YOUNGADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2008254513
INTERNATIONAL-SEARCH-REPORTUS2010221781
INTERNATIONAL-SEARCH-REPORTWO2011019619

Non-Patent Literature (NPL) Citations (2) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents